From University of Tasmania - Research to Reality:
A new University of Tasmania collaboration is aiming to bring the complexities of in-house laboratory testing to the fingertips of those in the field.
In a move promised to revolutionise the way complex samples are carried out, a $5.2 million Australian Research Council Training Centre for Portable Analytical Separation Technologies (ASTech) was established late last year.
The University has partnered with Australian company Trajan Scientific and Medical and the Federal Government to explore new technologies which ultimately bring the laboratory to the sample.
"What if you could carry out a full suite of tests on a pin-prick droplet of blood … What if you could carry out tests on your smartphone?"
Trajan Scientific and Medical’s hemaPEN® microsampling technology has been developed with extensive consultation and evaluation by leading analytical laboratories, clinicians and healthcare professionals.
This month, Trajan presents an exclusive interview with researcher Dr Michele Protti of Pharmaco-Toxicological Analysis, Bologna, Italy, on the future of microsampling and the critical role hemaPEN can play when used in therapeutic drug monitoring for optimal therapy personalization.
Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.